Cargando…
Cardiology clinic visit increases likelihood of evidence‐based cholesterol prescribing in severe hypercholesterolemia
BACKGROUND: Patients with phenotypic severe hypercholesterolemia (SH), low‐density lipoprotein‐cholesterol (LDL‐c) ≥ 190 mg/dl, atherosclerotic cardiovascular disease (ASCVD) or adults 40–75 years with diabetes with risk factors or 10‐year ASCVD risk ≥20% benefit from maximally tolerated statin ther...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Periodicals, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852174/ https://www.ncbi.nlm.nih.gov/pubmed/33355940 http://dx.doi.org/10.1002/clc.23521 |